Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer

• We present two cases of advanced uterine cancer that were treated with the combination of metronomic cyclophosphamide and bevacizumab. • Targeting angiogenesis can provide disease control in patients with advanced uterine cancer. • Randomized controlled trials comparing metronomic and conventional...

Descripción completa

Detalles Bibliográficos
Autores principales: Alagkiozidis, Ioannis, Lozano, Melissa, Devraj, Mithun, Lee, Yi-Chun, Abulafia, Ovadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442644/
https://www.ncbi.nlm.nih.gov/pubmed/26076153
http://dx.doi.org/10.1016/j.gore.2014.12.004
_version_ 1782372907925635072
author Alagkiozidis, Ioannis
Lozano, Melissa
Devraj, Mithun
Lee, Yi-Chun
Abulafia, Ovadia
author_facet Alagkiozidis, Ioannis
Lozano, Melissa
Devraj, Mithun
Lee, Yi-Chun
Abulafia, Ovadia
author_sort Alagkiozidis, Ioannis
collection PubMed
description • We present two cases of advanced uterine cancer that were treated with the combination of metronomic cyclophosphamide and bevacizumab. • Targeting angiogenesis can provide disease control in patients with advanced uterine cancer. • Randomized controlled trials comparing metronomic and conventional regimens in advanced uterine cancer are required.
format Online
Article
Text
id pubmed-4442644
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-44426442015-06-05 Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer Alagkiozidis, Ioannis Lozano, Melissa Devraj, Mithun Lee, Yi-Chun Abulafia, Ovadia Gynecol Oncol Rep Case Series • We present two cases of advanced uterine cancer that were treated with the combination of metronomic cyclophosphamide and bevacizumab. • Targeting angiogenesis can provide disease control in patients with advanced uterine cancer. • Randomized controlled trials comparing metronomic and conventional regimens in advanced uterine cancer are required. Elsevier 2015-02-04 /pmc/articles/PMC4442644/ /pubmed/26076153 http://dx.doi.org/10.1016/j.gore.2014.12.004 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Series
Alagkiozidis, Ioannis
Lozano, Melissa
Devraj, Mithun
Lee, Yi-Chun
Abulafia, Ovadia
Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
title Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
title_full Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
title_fullStr Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
title_full_unstemmed Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
title_short Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
title_sort metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442644/
https://www.ncbi.nlm.nih.gov/pubmed/26076153
http://dx.doi.org/10.1016/j.gore.2014.12.004
work_keys_str_mv AT alagkiozidisioannis metronomiccyclophosphamidewithbevacizumabprovidesdiseasestabilizationinpatientswithadvanceduterinecancer
AT lozanomelissa metronomiccyclophosphamidewithbevacizumabprovidesdiseasestabilizationinpatientswithadvanceduterinecancer
AT devrajmithun metronomiccyclophosphamidewithbevacizumabprovidesdiseasestabilizationinpatientswithadvanceduterinecancer
AT leeyichun metronomiccyclophosphamidewithbevacizumabprovidesdiseasestabilizationinpatientswithadvanceduterinecancer
AT abulafiaovadia metronomiccyclophosphamidewithbevacizumabprovidesdiseasestabilizationinpatientswithadvanceduterinecancer

Ejemplares similares